CLAIM CARD
Evidence-abstraction note.** The 41 retained reference papers are not 41 independent primary clinical trials: 41 are review, indirect, or mechanistic source-level summaries, and no source is classified as direct interventional hard-endpoint evidence, although human observational/prognostic evidence is present. Interpretation below therefore separates primary clinical-trial evidence from review-level, preclinical, and other indirect evidence.
Evidence grade: exploratory
Contradiction status: none
Publication: bd4ddec9-e10e-445f-bf0b-a5399dfae223
Provenance: Derivation Web chain
Citation Support
source_1Jongsma 2023source_2Xie 2025source_3Wallen 2024source_4Hoang 2025source_5Boudhabhay 2026